Thousand Oaks, CA, United States of America

Thomas J Kelleher


Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 54(Granted Patents)


Location History:

  • Weston, MA (US) (2004 - 2011)
  • Thousand Oaks, CA (US) (2012 - 2016)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Thomas J Kelleher

Introduction

Thomas J Kelleher is a notable inventor based in Thousand Oaks, CA, with a significant portfolio of seven patents. His work primarily focuses on advancements in lipid body compositions and high purity lipopeptides, which have important implications in pharmaceutical applications.

Latest Patents

Kelleher's latest patents include innovative methods and compositions related to lipid bodies isolated from yeast. These lipid bodies are characterized by their large size and high internal neutral lipid content, offering numerous advantages for practical applications. Additionally, he has developed methods for purifying daptomycin, a lipopeptide antibiotic, through advanced chromatography techniques. His inventions also encompass lipopeptide micelles and their therapeutic uses, showcasing his commitment to enhancing pharmaceutical formulations.

Career Highlights

Throughout his career, Kelleher has made significant contributions to the field of pharmaceuticals. He has worked with reputable companies such as Cubist Pharmaceuticals and Xylome Corporation, where he has applied his expertise in developing innovative solutions for drug formulations and delivery.

Collaborations

Kelleher has collaborated with esteemed colleagues, including Jan-Ji Lai and Joseph P DeCourcey, further enriching his research and development efforts in the pharmaceutical industry.

Conclusion

Thomas J Kelleher's contributions to the field of pharmaceuticals through his patents and collaborations highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…